ECM
IBB icon

Exchange Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Exchange Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-165
Closed -$18K – 238
2017
Q3 		$18K Buy
+165
New +$17.6K 0.01% 184
2016
Q3 		– Sell
-3
Closed – – 247
2016
Q2 		$0 Buy
+3
New +$269 ﹤0.01% 241
2014
Q3 		– Sell
-195
Closed -$17K – 232
2014
Q2 		$17K Hold
195
– – 0.01% 137
2014
Q1 		$15K Hold
195
– – 0.01% 156
2013
Q4 		$15K Hold
195
– – 0.01% 126
2013
Q3 		$14K Hold
195
– – 0.01% 124
2013
Q2 		$11K Buy
+195
New +$11.3K 0.01% 126

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Exchange Capital Management's IBB Position: Q4 2017 in Review

Exchange Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 165 shares — an estimated $18K sold.

Exchange Capital Management first reported a position in IBB in Q2 2013 and held it in 7 quarters. The position peaked at $18K in Q3 2017. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • Exchange Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
  • Exchange Capital Management sold 165 iShares Biotechnology ETF shares in Q4 2017, an estimated $18K.
  • Exchange Capital Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 7 quarters.
  • Exchange Capital Management's iShares Biotechnology ETF position peaked at $18K in Q3 2017.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on Exchange Capital Management's 13F filing for Q4 2017, filed 5 Feb 2018.